Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $2.360 million which beat the analyst consensus estimate of $2.252 million by 4.78 percent. This is a 6.12 percent decrease over sales of $2.514 million the same period last year.